Janson Pharmaceuticals incurred the following costs in 2013 related to a new cancer drug: Research for new formulas $ 2,425,000 Development of a new formula 1,600,000

Janson Pharmaceuticals incurred the following costs in 2013 related to a new cancer drug:

Research for new formulas $ 2,425,000

Development of a new formula 1,600,000

Legal and filing fees for a patent for the new formula 60,000

Total $ 4,085,000

The development costs were incurred after technological and commercial feasibility was established and after the future economic benefits were deemed probable. The project was successfully completed and the new drug was patented before the end of the 2013 fiscal year.

1.

Calculate the amount of research and development expense Janson should report in its 2013 income statement related to this project.

(I already have the answer for #1)

2.

Calculate the amount of research and development expense Janson should report in its 2013 income statement related to this project. Assuming that Janson prepares its financial statements according to International Financial Reporting Standards.

Leave a Comment